Several epidemiological studies have highlighted the potential health risks associated with HRT. The Women's Health Initiative (WHI) study, one of the largest and most comprehensive studies on HRT, found an increased risk of breast cancer, stroke, and venous thromboembolism in women using combined estrogen-progestin therapy. However, the risks vary depending on factors such as age, duration of therapy, and the type of hormones used.
